| |
| |
|
| Insider
Information: |
Mcnaughton Thomas |
| Relationship: |
Chief Financial Officer |
| City: |
Holliston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
185,347 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$706,509 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
185,347 |
|
|
| Total
Value |
$706,509 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Harvard Bioscience Inc |
HBIO |
Former Chief Financial... |
2013-11-01 |
171,613 |
2010-06-04 |
0 |
Premium* |
|
|
Biostage Inc |
BSTG |
Chief Financial Officer |
2018-06-15 |
13,734 |
2013-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSTG |
Biostage Inc |
Chief Financial Officer |
• – – |
2018-06-15 |
4 |
B |
$4.40 |
$11,000 |
D/D |
2,500 |
13,734 |
2.74 |
- |
|
| BSTG |
Biostage Inc |
Chief Financial Officer |
• – – |
2018-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
928 |
11,234 |
0 |
- |
|
| BSTG |
Biostage Inc |
Chief Financial Officer |
• – – |
2016-05-20 |
4 |
B |
$1.55 |
$7,775 |
D/D |
5,000 |
206,128 |
2.74 |
- |
|
| BSTG |
Biostage Inc |
Chief Financial Officer |
• – – |
2015-11-19 |
4 |
B |
$1.70 |
$17,000 |
D/D |
10,000 |
201,128 |
2.74 |
- |
|
| BSTG |
Biostage Inc |
Chief Financial Officer |
• – – |
2015-11-18 |
4 |
B |
$1.56 |
$15,600 |
D/D |
10,000 |
191,128 |
2.74 |
- |
|
| BSTG |
Biostage Inc |
Chief Financial Officer |
• – – |
2015-11-17 |
4 |
B |
$1.32 |
$19,800 |
D/D |
15,000 |
181,128 |
2.74 |
- |
|
| BSTG |
Biostage Inc |
Chief Financial Officer |
• – – |
2015-08-26 |
4 |
B |
$0.88 |
$8,800 |
D/D |
10,000 |
166,128 |
2.74 |
- |
|
| BSTG |
Biostage Inc |
Chief Financial Officer |
• – – |
2015-08-21 |
4 |
B |
$0.76 |
$19,000 |
D/D |
25,000 |
156,128 |
2.74 |
- |
|
| BSTG |
Biostage Inc |
Chief Financial Officer |
• – – |
2015-08-19 |
4 |
B |
$0.62 |
$46,500 |
D/D |
75,000 |
131,128 |
2.74 |
- |
|
| BSTG |
Biostage Inc |
Interim CEO & CFO |
• – – |
2015-06-03 |
4 |
B |
$2.01 |
$10,050 |
D/D |
5,000 |
56,128 |
2.74 |
- |
|
| BSTG |
Biostage Inc |
Interim CEO & CFO |
• – – |
2015-06-02 |
4 |
B |
$1.80 |
$14,400 |
D/D |
8,000 |
51,128 |
2.74 |
- |
|
| BSTG |
Biostage Inc |
Interim CEO & CFO |
• – – |
2015-06-01 |
4 |
B |
$1.74 |
$5,220 |
D/D |
3,000 |
43,128 |
2.74 |
- |
|
| BSTG |
Biostage Inc |
Interim CEO & CFO |
• – – |
2015-05-29 |
4 |
B |
$1.91 |
$9,550 |
D/D |
5,000 |
40,128 |
2.74 |
- |
|
| BSTG |
Biostage Inc |
Chief Financial Officer |
• – – |
2015-02-13 |
4 |
B |
$2.91 |
$10,185 |
D/D |
3,500 |
35,128 |
2.74 |
- |
|
| BSTG |
Biostage Inc |
Chief Financial Officer |
• – – |
2015-02-12 |
4 |
B |
$2.59 |
$27,195 |
D/D |
10,500 |
31,628 |
2.74 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Former Chief Financial Officer |
– – – |
2013-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
25,192 |
171,613 |
0 |
- |
|
| BSTG |
Biostage Inc |
Chief Financial Officer |
• – – |
2013-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
21,128 |
21,128 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2013-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
19,337 |
146,420 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2012-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
41,273 |
127,083 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2011-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
85,810 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2011-01-25 |
4 |
D |
$4.08 |
$24,439 |
D/D |
(5,990) |
60,810 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
• – – |
2010-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
66,800 |
66,800 |
0 |
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
